Search results
Cellectis S.A. (NASDAQ:CLLS) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoCellectis S.A. (NASDAQ:CLLS) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good...
AstraZeneca ups stake in Cellectis in latest cell therapy bet
BioPharma Dive via Yahoo Finance· 1 month agoThe British drugmaker, which has made genetic medicine a larger priority of late, added $140 million...
AstraZeneca concludes equity investment in Cellectis
Pharmaceutical Technology via Yahoo Finance· 1 month agoAstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis. The investment comes after the companies entered an...
AstraZeneca to invest $245 million in Cellectis to boost gene therapy prospects
Reuters via AOL· 7 months agoCellectis' gene-editing technology and manufacturing capabilities to design novel cell and gene...
Cellectis Touts Positive Preliminary Data From Two Leukemia Trials
Benzinga via Yahoo Finance· 1 year agoCellectis S.A (NASDAQ: CLLS) highlighted updated clinical data on its Phase 1/2a BALLI-01 trial...
These 2 “Strong Buy” Penny Stocks Could Gain Over 500%, Says Baird
TipRanks via Yahoo Finance· 8 months agoIn the classic tune by Kenny Rogers, ‘The Gambler,’ he sang, ‘Every hand’s a winner and every hand’s...
Iovance (IOVA) Doses First Patient in TIL Cancer Therapy Study
Zacks via Yahoo Finance· 2 years agoIovance (IOVA) doses the first patient in phase I/II study evaluating its TIL therapy candidate,...
7 CRISPR Stocks With the Best Long-Term Potential
InvestorPlace via Yahoo Finance· 1 year agoCRISPR technology has the potential to revolutionize the way we approach medicine. This technology has already been used in a variety of applications,...
Seer, Inc. (SEER) Stock Jumps 12.9%: Will It Continue to Soar?
Zacks via Yahoo Finance· 2 years agoSeer, Inc. (SEER) saw its shares surge in the last session with trading volume being higher than...
Iovance's (IOVA) Q3 Earnings Beat Estimates, Revenues Nil
Zacks via Yahoo Finance· 2 years agoIovance Biotherapeutics (IOVA) reports a wider-than-expected loss in Q3. The company is on track to...
